BIOQ.US Bioqual Inc

Healthcare Biotechnology USA Stocks
31.00 USD
Close of Nov 13, 2026
30.64 38.51
Market cap
USD 27.7M
P/E
11.8x
P/B
1.00x
ROE
-6.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Aug 2026.

Is BIOQ.US undervalued?

Graham number
Price31.00
Graham value42.83
Discount27.6%

BIOQ.US trades 27.6% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Bioqual Inc fundamental analysis

No fundamental analysis for Bioqual Inc yet.

Bioqual Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Bioqual Inc

Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides contract research services in the areas of AIDS, influenza, respiratory syncytial virus, Coronavirus, malaria, hepatitis, cancer, and other infectious diseases, as well as flavivirus infections, including zika and dengue. It also offers small and large animal models. In addition, the company provides cell-based assays, imm…

Full company profile